0R15 8520.0 0.0% 0R1E 8203.0 0.0% 0M69 21090.0 67.5139% 0R2V 226.02 9878.8079% 0QYR None None% 0QYP 412.97 -2.8306% 0RUK 2652.0 -9.2402% 0RYA 1554.0 -0.7029% 0RIH 174.55 -1.3563% 0RIH 165.15 -5.3853% 0R1O 198.5 9800.2494% 0R1O None None% 0QFP None None% 0M2Z 267.777 -0.1763% 0VSO 32.05 -9.9846% 0R1I None None% 0QZI 559.0 0.7207% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 165.7358 2.7149%
Last update at 2024-11-21T16:30:00Z
Target Healthcare REIT PLC (LON:THRL) is a favorite amongst institutional investors who own 85%
Sat 28 Jan 23, 09:04 AMTarget Healthcare REIT Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
Tue 08 Nov 22, 05:59 AMTarget Healthcare REIT PLC Just Missed Earnings - But Analysts Have Updated Their Models
Sun 16 Oct 22, 07:03 AMShareholders in Target Healthcare REIT (LON:THRL) are in the red if they invested a year ago
Tue 13 Sep 22, 05:25 AMWhat Type Of Shareholders Make Up Target Healthcare REIT PLC's (LON:THRL) Share Registry?
Wed 27 Oct 21, 10:40 AM| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | -6.57200M | 49.10M | 43.88M | 31.62M | 29.88M |
| Minority interest | - | - | - | - | - |
| Net income | -6.57200M | 49.10M | 43.88M | 31.62M | 29.88M |
| Selling general administrative | 2.63M | 2.68M | 2.37M | 4.31M | 2.74M |
| Selling and marketing expenses | 0.23M | 0.33M | 0.21M | 0.18M | 0.08M |
| Gross profit | -3.26200M | 55.50M | 49.21M | 35.93M | 32.63M |
| Reconciled depreciation | - | - | - | - | - |
| Ebit | 55.77M | 55.77M | 38.85M | 34.74M | 26.83M |
| Ebitda | -6.57200M | 49.10M | 43.89M | 31.62M | 33.05M |
| Depreciation and amortization | -0.56800M | -0.56800M | - | - | - |
| Non operating income net other | - | - | - | - | - |
| Operating income | -6.57200M | 49.10M | 43.89M | 31.62M | 33.05M |
| Other operating expenses | 64.88M | 8.16M | 1.29M | 8.37M | 2.74M |
| Interest expense | 10.27M | 6.67M | 5.76M | 5.53M | 3.17M |
| Tax provision | 0.00000M | 0.00600M | -0.00800M | -0.00300M | 0.00000M |
| Interest income | 0.13M | 0.07M | 0.04M | 0.11M | 0.06M |
| Net interest income | -10.13600M | -6.60000M | -4.23700M | -3.50500M | -3.10400M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.00600M | 0.00600M | -0.00800M | -0.00300M | - |
| Total revenue | -3.26200M | 55.50M | 49.21M | 35.93M | 32.63M |
| Total operating expenses | 3.31M | 6.39M | 5.33M | 4.31M | 2.74M |
| Cost of revenue | - | - | - | - | 4.70M |
| Total other income expense net | -6.57200M | 49.10M | 43.88M | 31.62M | -3.16500M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -6.57200M | 49.10M | 43.88M | 31.62M | 29.88M |
| Net income applicable to common shares | -6.57200M | 49.10M | 43.88M | 31.62M | 29.88M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 908.26M | 963.66M | 718.39M | 663.77M | 538.38M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 13.20M | 7.70M | 7.32M | 7.50M | 0.66M |
| Total liab | 253.45M | 264.89M | 153.21M | 169.66M | 125.29M |
| Total stockholder equity | 654.81M | 698.77M | 565.18M | 494.11M | 413.09M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | -18.30600M | -26.36300M | -18.46500M | -13.11400M | -11.80200M |
| Common stock | 6.20M | 6.20M | 5.12M | 4.58M | 372.69M |
| Capital stock | 6.20M | 6.20M | 5.12M | 4.58M | 372.69M |
| Retained earnings | 298.28M | 302.15M | 312.73M | 319.03M | 4.95M |
| Other liab | 8.09M | 7.14M | 6.84M | 6.18M | 6.36M |
| Good will | - | - | - | - | - |
| Other assets | 92.74M | 71.48M | 66.13M | 57.25M | 538.38M |
| Cash | 15.37M | 34.48M | 21.11M | 36.44M | 26.95M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 18.31M | 26.36M | 18.46M | 13.11M | 11.80M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 211.69M | 196.90M | 106.80M | 113.69M | 79.47M |
| Short term debt | - | - | - | - | - |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 227.05M | 231.38M | 127.90M | 150.13M | 106.42M |
| Other stockholder equity | -304.48400M | -308.34900M | -317.84300M | -323.60100M | 40.40M |
| Property plant equipment | 800.15M | 857.69M | 629.61M | 570.09M | 469.60M |
| Total current assets | 15.37M | 34.48M | 21.11M | 36.44M | 68.78M |
| Long term investments | 6.91M | 2.28M | 0.25M | - | - |
| Net tangible assets | 654.81M | 698.77M | 565.18M | 494.11M | 413.09M |
| Short term investments | - | - | - | - | - |
| Net receivables | 85.83M | 69.20M | 60.11M | 49.75M | 41.84M |
| Long term debt | - | - | - | - | 107.13M |
| Inventory | - | - | - | - | - |
| Accounts payable | 18.31M | 26.36M | 18.46M | 13.11M | 11.80M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 4.58M | 372.69M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -6.90500M | -2.28400M | -0.25100M | -570.08600M | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 800.15M | 857.69M | 631.16M | 570.09M | - |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -3.55300M | -202.63300M | -43.57500M | -103.41500M | -99.61500M |
| Change to liabilities | -0.32500M | 4.59M | 1.86M | 0.37M | 2.06M |
| Total cashflows from investing activities | -3.55300M | -202.63300M | -43.57500M | -103.41500M | -99.61500M |
| Net borrowings | -4.75000M | 104.75M | -22.00000M | 44.00M | 42.00M |
| Total cash from financing activities | -45.22900M | 185.62M | 3.29M | 91.44M | 67.00M |
| Change to operating activities | - | -1.25000M | -1.55000M | -1.55000M | -1.55000M |
| Net income | -6.57200M | 49.10M | 43.88M | 31.62M | 29.88M |
| Change in cash | -19.11700M | 13.38M | -15.33400M | 9.49M | -14.45400M |
| Begin period cash flow | 34.48M | 21.11M | 36.44M | 26.95M | 41.40M |
| End period cash flow | 15.37M | 34.48M | 21.11M | 36.44M | 26.95M |
| Total cash from operating activities | 29.66M | 30.39M | 24.96M | 21.47M | 18.16M |
| Issuance of capital stock | 0.00000M | 125.00M | 60.00M | 80.00M | 50.00M |
| Depreciation | - | - | 0.04M | 0.04M | 0.00800M |
| Other cashflows from investing activities | - | - | 0.15M | 0.12M | -0.18500M |
| Dividends paid | 40.27M | 39.78M | 31.49M | 29.15M | 23.63M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | -4.55000M | -3.76800M | -1.23200M | -1.23800M | -2.06000M |
| Sale purchase of stock | - | -7.75000M | 114.00M | 38.00M | 0.95M |
| Other cashflows from financing activities | 61.80M | 225.40M | 34.78M | 120.59M | 40.62M |
| Change to netincome | 40.49M | -18.84500M | -18.57900M | -10.05700M | -12.35100M |
| Capital expenditures | 0.00000M | 0.00000M | 0.71M | 0.57M | 0.88M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -4.87500M | -0.42800M | -0.92300M | -0.86800M | -0.00300M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | 41.11M | -18.28300M | -17.99700M | -9.28200M | -11.71700M |
| Free cash flow | 29.66M | 30.39M | 24.96M | 21.47M | 18.16M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
| Company | Change (GBP) | Price (GBP) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| THRL Target Healthcare REIT Ltd |
-0.8 0.95% | 83.50 | - | 14.35 | 7.47 | 0.82 | 5.13 | 26.25 |
| AGR Assura PLC |
- -% | 38.32 | - | 12.95 | 9.40 | 0.91 | 16.89 | -18.2888 |
| PHP Primary Health Properties |
- -% | 93.00 | - | 14.84 | 8.81 | 0.92 | 70.21 | |
| LABS Life Science REIT PLC |
-1.4 3.53% | 38.30 | - | - | 37.01 | 0.69 |
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group's portfolio at 30 June 2023 comprised 97 assets let to 32 tenants with a total value of £868.7 million. The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
Broadgate Tower, London, United Kingdom, EC2A 2EW
| Name | Title | Year Born |
|---|---|---|
| Mr. Kenneth Macangus MacKenzie C.A., M.A., MA CA | Founder & Chief Exec. of Target Fund Mang.s Limited | 1950 |
| Mr. Gordon Bland BAcc CA, C.A. | Fin. Director of Target Fund Mang.s Limited | NA |
| Mr. John Flannelly BAcc FCA, F.C.A. | Head of Investment - Target Fund Mang.s Limited | NA |
| Mr. Andrew Brown | Head of Healthcare - Target Fund Mang.s Limited | NA |
| Mr. Scott Steven M.A. | Head of Asset Management - Target Fund Mang.s Limited | NA |
| Mr. Donald Cameron B.Com., C.A. | Company Sec. & Director of Financial Reporting - Target Fund Mang.s Limited | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
UK 
AU
CA
US
NZ
Please wait processing your request...